Back to results
US 2026/0083849 A1Published application
Modified t-cells for use in the treatment of bladder cancer
AssigneeUswm Ct, LLC
InventorsStephen DAWE, Alejandro GARCIA-CONSUEGRA LÓPEZ-PICAZO, José María SARO SUAREZ
Life of this patent
Estimating the term…
Abstract
The disclosure relates to a method of treating bladder cancer, and to a population of modified immunoresponsive cells expressing a heterologous TCR for use in such method.
Claims15
A method of treating bladder cancer in an individual, comprising administering to the individual a population of modified T cells comprising a heterologous T-cell receptor (TCR) capable of binding to a peptide antigen of MAGE-A4.
Dependencies are inferred from the claim text.